Search Results - David Clayton

David Clayton

David George Clayton (born 13 June 1944), is a British statistician and epidemiologist. He is titular Professor of Biostatistics in the University of Cambridge and Wellcome Trust and Juvenile Diabetes Research Foundation Principal Research Fellow in the Diabetes and Inflammation Laboratory, where he chairs the statistics group. Clayton is an ISI highly cited researcher placing him in the top 250 most cited scientists in the mathematics world over the last 20 years. Provided by Wikipedia
  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Editorial: Body composition and cardiovascular health by Ian G. Davies, David Clayton, Richard Kirwan, Michael A. Schmidt

    Published in Frontiers in Nutrition (2024-05-01)
    Get full text
    Article


  2. 2

    “Like another human being in the room”: a community case study of smart speakers to reduce loneliness in the oldest-old by Arlene Astell, Arlene Astell, Arlene Astell, Arlene Astell, Arlene Astell, David Clayton

    Published in Frontiers in Psychology (2024-04-01)
    Get full text
    Article


  3. 3

    Extreme clonality in lymphoblastoid cell lines with implications for allele specific expression analyses. by Vincent Plagnol, Elif Uz, Chris Wallace, Helen Stevens, David Clayton, Tayfun Ozcelik, John A Todd

    Published in PLoS ONE (2008-08-01)
    Get full text
    Article


  4. 4

    Resting-state functional magnetic resonance imaging in a randomized clinical trial for Alzheimer's disease by David Clayton, Alexandre Coimbra, Farshid Faraji, Thomas Bengtsson, Lee Honigberg, William Cho, Robert Paul, Alex de Crespigny

    Published in NeuroImage: Reports (2021-12-01)
    Get full text
    Article


  5. 5

    Determining Spatial Responses of Fishers (<i>Pekania Pennanti</i>) to Mechanical Treatments of Forest Stands for Fuel Reduction by Tessa R. Smith, Eric M. Gese, R. David Clayton, Patricia A. Terletzky, Kathryn L. Purcell, Craig M. Thompson

    Published in Animals (2025-02-01)
    Get full text
    Article


  6. 6

    Deformation-based morphometry identifies deep brain structures protected by ocrelizumab by Zhuang Song, Anithapriya Krishnan, Laura Gaetano, Nicholas J. Tustison, David Clayton, Alex de Crespigny, Thomas Bengtsson, Xiaoming Jia, Richard A.D. Carano

    Published in NeuroImage: Clinical (2022-01-01)
    Get full text
    Article


  7. 7

    Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a by Shannon Kolind, Shawna Abel, Carolyn Taylor, Roger Tam, Cornelia Laule, David K.B. Li, Hideki Garren, Laura Gaetano, Corrado Bernasconi, David Clayton, Irene Vavasour, Anthony Traboulsee

    Published in NeuroImage: Clinical (2022-01-01)
    Get full text
    Article


  8. 8

    In PLoS Biology, volume 1, issue 1:: Candidate Gene Association Study in Type 2 Diabetes Indicates a Role for Genes Involved in β-Cell Function as Well as Insulin Action. by Inês Barroso, Jian'an Luan, Rita P. S Middelberg, Anne-Helen Harding, Paul W Franks, Rupert W Jakes, David Clayton, Alan J Schafer, Stephen O'Rahilly, Nicholas J Wareham

    Published in PLoS Biology (2003-12-01)
    Get full text
    Article


  9. 9

    Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mil... by Stephen Salloway, Lee A. Honigberg, William Cho, Michael Ward, Michel Friesenhahn, Flavia Brunstein, Angelica Quartino, David Clayton, Deborah Mortensen, Tobias Bittner, Carole Ho, Christina Rabe, Stephen P. Schauer, Kristin R. Wildsmith, Reina N. Fuji, Shehnaaz Suliman, Eric M. Reiman, Kewei Chen, Robert Paul

    Published in Alzheimer’s Research & Therapy (2018-09-01)
    Get full text
    Article


Search Tools: